---
content_type: page
title: Lectures and Readings
uid: 52e203d2-2d0d-9bb1-0143-e079117c1785
---

This page presents lecture materials presented during selected class sessions, along with assigned readings.

| SES # | TOPICS | INSTRUCTORS | LECTURES | READINGS |
| --- | --- | --- | --- | --- |
| 1 | Introduction to the course | All | (![This resource may not render correctly in a screen reader.](/images/inacessible.gif)[PDF - 2.3MB]({{< baseurl >}}/resources/mit20_380js10_lec01_intro)) | &nbsp; |
| Background: Inflammation in healthy immune response | Irvine | ([PDF - 1.2MB]({{< baseurl >}}/resources/mit20_380js10_lec01_di)) |
| 2 | Background: Inflammation and cancer | Irvine | &nbsp; |  {{< br >}}{{< br >}} Vakkila, J., and M. T. Lotze. "[Inflammation and Necrosis Promote Tumor Growth](http://dx.doi.org/10.1038/nri1415)." _Nature Reviews Immunology_ 4 (August 2004): 641-648. {{< br >}}{{< br >}} Wu, Y., and B. P. Zhou. "[Inflammation: A Driving Force Speeds Cancer Metastatis](http://www.ncbi.nlm.nih.gov/pubmed/19770594)." _Cell Cycle_ 8, no. 20 (2009): 3267-3273. {{< br >}}{{< br >}} Yu, H., D. Pardoll, and R. Jove. "[STATs in Cancer Inflammation and Immunity: A Leading Role for STAT3](http://dx.doi.org/10.1038/nrc2734)." _Nature Reviews Cancer_ 9 (November 2009): 798-809. {{< br >}}{{< br >}}  |
| 3 | Background: Inflammation in obesity and diabetes | White | ([PDF - 5.0MB]({{< baseurl >}}/resources/mit20_380js10_lec03_fw)) |  {{< br >}}{{< br >}} Shoelson, S. E., L. Herrero, and A. Naaz. "[Obesity, Inflammation, and Insulin Resistance](http://www.gastrojournal.org/article/S0016-5085(07)00585-9/abstract)." _Gastroenterology_ 132 (2007): 2169-2180. {{< br >}}{{< br >}} Tauben, G. "[Prosperity's Plague](http://www.sciencemag.org/cgi/content/summary/325/5938/256)." _Science_ 325 (July 17, 2009): 256-260. {{< br >}}{{< br >}} Wellen, K. E., and G. S. Hotamisligil. "[Inflammation, Stress, and Diabetes](http://www.jci.org/articles/view/25102)." _The Journal of Clinical Investigation_ 115, no. 5 (2005): 1111-1119. {{< br >}}{{< br >}}  |
| 4 | Background: Inflammation in cardiovascular disease | Essigmann | (![This resource may not render correctly in a screen reader.](/images/inacessible.gif)[PDF - 8.3MB]({{< baseurl >}}/resources/mit20_380js10_lec04_je)) |  {{< br >}}{{< br >}} Libby, P., P. M. Ridker, and G. K. Hansson. "[Inflammation in Atherosclerosis: From Pathophysiology to Practice](http://dx.doi.org/10.1016/j.jacc.2009.09.009)." _Journal of the American College of Cardiology_ 54, no. 23 (2009): 2129-2138. {{< br >}}{{< br >}} Tabas, I. "[Macrophage Death and Defective Inflammation Resolution in Atherosclerosis](http://www.nature.com/nri/journal/v10/n1/abs/nri2675.html)." _Nature Reviews Immunology_ 10 (January 2010): 36-46. {{< br >}}{{< br >}}  |
| 7-8 | Technical paper presentations | &nbsp; |  {{< br >}}{{< br >}} **Cancer** {{< br >}}{{< br >}} Ditsworth, D., W.-X. Zong, and C. B. Thompson. "[Activation of Poly(ADP)-Ribose Polymerase (PARP-1) Induces Release of the Pro-Inflammatory Mediator HMGB1 from the Nucleus](http://www.jbc.org/content/282/24/17845)." _The Journal of Biological Chemistry_ 282, no. 24 (2007): 17845-17854. {{< br >}}{{< br >}} Schafer, Z. T., et al. "[Antioxidant and Oncogene Rescue of Metabolic Defects Caused by Loss of Matrix Attachment](http://dx.doi.org/10.1038/nature08268)." _Nature_ 461 (2009): 109-113. {{< br >}}{{< br >}} **Obesity/Diabetes** {{< br >}}{{< br >}} Cao, H., et al. "[Identification of a Lipokine, a Lipid Hormone Linking Adipose Tissue to Systemic Metabolism](http://www.cell.com/retrieve/pii/S0092867408010143)." _Cell_ 134, no. 6 (2008): 933-944. {{< br >}}{{< br >}} Nishimura, S., et al. "[CD8+ Effector T cells Contribute to Macrophage Recruitment and Adipose Tissue Inflammation in Obesity](http://dx.doi.org/10.1038/nm.1964)." _Nature Medicine_ 15, no. 8 (2009): 914-920. {{< br >}}{{< br >}} **Cardiovascular Disease** {{< br >}}{{< br >}} Erbay, E., et al. "[Reducing Endoplasmic Reticulum Stress Through a Macrophage Lipid Chaperone Alleviates Atherosclerosis](http://dx.doi.org/10.1038/nm.2067)." _Nature Medicine_ 15 (2009): 1383-1391. {{< br >}}{{< br >}} Mandinov, L., et al. "[Copper Chelation Represses the Vascular Response to Injury](http://www.pnas.org/content/100/11/6700)." _PNAS_ 100, no. 11 (2003): 6700-6705. {{< br >}}{{< br >}}  |
| 14 | Workshop: Patents | Robert Langer | &nbsp; |  {{< br >}}{{< br >}} _Read the "Claims" sections of these patents. (Hint: some patents are good and others less so.)_ {{< br >}}{{< br >}} Bossert, F., et al. "[Coronary Dilator in a Pharmaceutical Dosage Unit Form](https://www.google.com/patents/US3784684)." US Patent 3784684, filed August 21, 1972 and issued January 8, 1974. {{< br >}}{{< br >}} Domb, A. J., and R. S. Langer. "[High Molecular Weight Polyanhydride and Preparation Thereof](https://www.google.com/patents/US4757128)." US Patent 4757128, filed August 1, 1986 and Issued July 12, 1988. {{< br >}}{{< br >}} Carey, M. C., A. C. Moses, and J. S. Fler. "[Drug Administration](https://www.google.com/patents/US4548922)." US Patent 4548922, filed June 6, 1983 and issued October 22, 1985. {{< br >}}{{< br >}} Folkman, M. J., and R. S. Langer. "[Systems for the Controlled Release of Macromolecules](https://www.google.com/patents/US4391797)." US Patent 4391797, filed August 10, 1981 and issued July 5, 1983. {{< br >}}{{< br >}} Bell, E. "[Tissue-Equivalent and Method for Preparation Thereof](https://www.google.com/patents/US4485096)." US Patent 4485096, filed May 26, 1982 and issued November 27, 1984. {{< br >}}{{< br >}} Mears, D. C. "[Regeneration of Living Tissues by Growth of Isolated Cells in Porous Implant and Product Thereof](https://www.google.com/patents/US4553272)." US Patent 4553272, filed February 26, 1981 and issued November 19, 1985. {{< br >}}{{< br >}} Hewick, R. M., and J. S. Seehra. "[Method for the Purification of Erythropoietin and Erythropoietin Compositions](https://www.google.com/patents/US4677195)." US Patent 4677195, filed January 11, 1985 and issued June 30, 1987. {{< br >}}{{< br >}} Schlatter, J. M. "[Peptide Sweetening Agents](https://www.google.com/patents/US3492131)." US Patent 3492131, filed April 18, 1966 and issued January 27, 1970. {{< br >}}{{< br >}}  |
| 15 | Workshop: Regulatory agencies and clinical trials | Essigmann | ([PDF - 1.3MB]({{< baseurl >}}/resources/mit20_380js10_lec15_je)) | &nbsp; |
| 17  {{< br >}}  | Workshop: Signaling networks | White | (![This resource may not render correctly in a screen reader.](/images/inacessible.gif)[PDF - 2.0MB]({{< baseurl >}}/resources/mit20_380js10_wk17_fw)) | &nbsp; |
| Communications Review 2 |  Banuazizi | &nbsp; | The class will divide into your teams and analyze particular sections of a pancreatic cancer paper. |
| 18  {{< br >}}  | Workshop: Drug targeting | Irvine | (![This resource may not render correctly in a screen reader.](/images/inacessible.gif)[PDF - 2.0MB]({{< baseurl >}}/resources/mit20_380js10_wk18_di_trgt)) | &nbsp; |
| Workshop: Drug carriers | Irvine | (![This resource may not render correctly in a screen reader.](/images/inacessible.gif)[PDF - 1.9MB]({{< baseurl >}}/resources/mit20_380js10_wk18_fw_care))